a, b, c, ¶ | |||
---|---|---|---|
Variable | n | % | |
Sex | |||
Male | 34 | 70.8 | |
Female | 14 | 29.2 | |
Age [median: 43 years (26–72)] | |||
< 45 | 26 | 54.2 | |
≥ 45 years | 22 | 45.8 | |
Time to metastasisa [median: 13.2 months (0–140.1)] | |||
at primary diagnosis (M1) | 14 | 29.2 | |
during follow up (M0) [median: 27.5 m] | 34 | 70.8 | |
< 24 months | 16 | 33.3 | |
≥ 24 | 12 | 25.0 | |
≥ 60 | 6 | 12.5 | |
Number of metastasis at the initial diagnosis of metastasis | |||
single | 25 | 52.1 | |
multiple | 23 | 47.9 | |
Location of metastasisb (number of patients) | |||
lung | 9 | 18.8 | |
extrapulmonary metastasis | 45 | 93.8 | |
bone | 15 | 31.3 | |
abdomen or retroperitoneum | 11 | 22.9 | |
liver | 9 | 18.8 | |
other soft tissuesc | 23 | 47.9 | |
Size of the largest metastasis [median: 5 cm (1–20)] | |||
< 10 cm | 37 | 82.2 | |
≥ 10 | 8 | 17.8 | |
Diagnostic modality for the first metastasis | |||
CT with contrast enhancement | 22 | 45.8 | |
CT without contrast enhancement | 13 | 27.1 | |
MRI | 11 | 22.9 | |
PET-CT | 1 | 2.1 | |
Others | 1 | 2.1 |